• Dong-Xu Zhao, Ping Chen, Cui-Hong Su, Yan-Yan Zhao, Li-Dan Sun, Hong He, and Xiao-Na Feng.
• Department of Obstetrics and Gynecology, First Affiliated Hospital of Jiamusi University, Jiamusi.
• Medicine (Baltimore). 2020 Jun 19; 99 (25): e20537.

BackgroundThis study aims to assess the efficacy and safety of weekly paclitaxel (WP) for the treatment of advanced ovarian cancer (AOC).MethodsThis study will systematically search bibliographic databases (MEDLINE, EMBASE, Cochrane Library, Web of Science, CINAHL, PSYCINFO, Allied and Complementary Medicine Database, CNKI, WANGFANG, and Chinese Biomedical Literature Database) and other literature sources from inception to the March 1, 2020 without language and publication time limitations. Two authors will independently complete all literature selection, data collection, and study quality evaluation. Any disagreements will be solved by a third author through discussion. We will analyze data by RevMan V.5.3 software.ResultsThis study will systematically generate a comprehensive summary on the efficacy and safety of WP for the treatment of AOC.ConclusionThis study may provide beneficial evidence of WP for the treatment of AOC.Systematic Review RegistrationINPLASY202040193.

19 keywords...

hide…